Print Page   |   Contact Us   |   Sign In   |   Join
News and Press: Policy News

FDA Offers Free, Continuing Education Course to Help Health Care Providers Understand ‘Biosimilars’

Monday, February 22, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

You may have heard about a new category of products called “biosimilars.” What are biosimilars and how do they relate to biological products already widely in use?


Biological products derived from living organisms can treat patients with cancer, chronic kidney disease, rheumatoid arthritis, inflammatory bowel disease, and other serious conditions. Biological products that are “biosimilar” to, or “interchangeable” with, an already-approved FDA biological product (an FDA-licensed reference product) are one way to improve access and increase treatment options at potentially lower cost for our nation’s health care system.

These products are licensed through a new pathway created in the United States in 2009. FDA is well aware that health care professionals–including prescribers, the nurses who will administer them, and the pharmacists who will dispense them–need to understand how these drugs work and how they are intended to be used.

Read more.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by®  ::  Legal